trial
as of 2026-07-01Horyzons: Implementation in Clinical Practice
NCTId NCT04673851
at a glance
— · Completed
Enrollment 85 (actual)
Sponsored by University of North Carolina, Chapel Hill
Primary completion 2023-08-31
Synthesized from structured facts only — each point cited above.
Design & status
Phase
—
Status
Completed
Enrollment
85 (actual)
Study type
Interventional
Allocation
Non Randomized
Model
Parallel
Masking
None
Start
2021-01-19
Primary completion
2023-08-31
Eligibility
ALL · 16 Years · 35 Years
Interventions & indications
Sponsors
University of North Carolina, Chapel HillLead Sponsor
Investigators
2
David L. Penn, PhDPrincipal Investigator
Diana O. Perkins, MD, MPHPrincipal Investigator
Sites
1 total
Chapel Hill, United States
Facts & assertions
4 sourced
Enrollment
85
Phase
NA
Primary Completion Date
2023-08-31
Status
COMPLETED
relationships
The graph out of here
drug
drug
lead_sponsor
collaborator
indication
indication
indication
investigator
person